22 July 202123 July 202124 July 2021
14.00 – 14.30 Welcome and Rising Star Session
14.30 – 15.00 SO1. An update on treatment of anxiety disorders
Borwin Bandelow (Germany)
15.00 – 15.10 Discussion
15.10 – 15.40 SO2. Psychobiotics for stress Disorders
Ted Dinan (UK)
15.40 – 15.50 Discussion
15.50 – 16.20 SO3. Functional outcome of bipolar disorders
Allan Young (UK)
16.20 – 16.30 Discussion
16.30 – 17.00 Coffee break
17.00 – 17.30 SO4. Mental health effects of the COVID-19 pandemic
Carmen Moreno (Spain)
17.30 – 17.40 Discussion
17.40 – 18.10 SO5. Depression as an episodic condition
Philip Goorwood (France)
18.10 – 18.20 Discussion
18.30 – 19.30 Welcome Reception
08.00 – 09.00 Strolling Poster
09.00 – 09.30 SO6. Novel Antipsychotics
Eduard Vieta (Spain)
09.30 – 09.40 Discussion
09.40 – 10.10 SO7. Treatment Resistant Depression: findings from an European study
Siegfried Kasper (Austria)
10.10 – 10.20 Discussion
10.20 – 10.50 SO8. Psychedelics in Psychiatry
Sidney Kennedy (Canada)
10.50 – 11.00 Discussion
11.00 – 11.30 Coffee break
11.30 – 13.00 Supported Symposium
13.00 – 14.00 Lunch
14.00 – 14.30 SO9. Impulsive and compulsive disorders
Naomi Fineberg (UK)
14.30 – 14.40 Discussion
14.40 – 15.10 S10. Personalised Psychiatry. Are we there yet?
Chiara Fabbri (Italy)
15.10 – 15.20 Discussion
15.20 – 15.50 S11. Hazards in the treatment of anxiety and depression: findings from the National Clinical Audit of Anxiety and Depression
David Baldwin (UK)
15.50 – 16.00 Discussion
16.00 – 16.30 Coffee break
16.30 – 17.00 S12. Are polygenic risk scores useful for treatment choice ?
Alessandro Serretti (Italy)
17.00 – 17.10 Discussion
17.10 – 17.40 S13. Prevention of suicide
Philippe Courtet (France)
17.40 – 17.50 Discussion
08.45 – 09.30 Poster Awards
09.30 – 10.00 S14. Depression and substance use disorders: state of the art
Marta Torrens Melich (Spain)
10.00 – 10.10 Discussion
10.10 – 10.40 S15. Inflammation in Mood and Anxiety Disorder
Bernard Baune (Germany)
10.40 – 10.50 Discussion
10.50 – 11.20 S17. Treatment of schizophrenia: is monotherapy the gold standard?
Istvan Bitter (Hungary)
11.20 – 11.30 Discussion
11.30- 12.00 Closing remarks
12.00 – 12.30 Farewell coffee
17.50 – 18.15 POSTER Awards